1 - 25 of 211 results for author:"Nakano H." in Literature citations
Results Customize
› Repeat search in UniProtKB (352)
| Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice. Minami T., Kuwahara K., Nakagawa Y., Takaoka M., Kinoshita H., Nakao K., Kuwabara Y., Yamada Y., Yamada C., Shibata J. et al. EMBO J. 31:4428-4440(2012) · Mapped (6) |
| Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium. Van Handel B., Montel-Hagen A., Sasidharan R., Nakano H., Ferrari R., Boogerd C.J., Schredelseker J., Wang Y., Hunter S., Org T. et al. Cell 150:590-605(2012) · Mapped (72) |
| TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88. Ohnishi H., Tochio H., Kato Z., Kawamoto N., Kimura T., Kubota K., Yamamoto T., Funasaka T., Nakano H., Wong R.W. et al. PLoS ONE 7:e38423-e38423(2012) · Mapped (13) |
| Rational evolution of a novel type of potent and selective proviral integration site in Moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound. Nakano H., Saito N., Parker L., Tada Y., Abe M., Tsuganezawa K., Yokoyama S., Tanaka A., Kojima H., Okabe T. et al. J. Med. Chem. 55:5151-5164(2012) · Mapped (1) |
| ATP binding cassette transporter G1 deletion induces IL-17-dependent dysregulation of pulmonary adaptive immunity. Draper D.W., Gowdy K.M., Madenspacher J.H., Wilson R.H., Whitehead G.S., Nakano H., Pandiri A.R., Foley J.F., Remaley A.T., Cook D.N. et al. J. Immunol. 188:5327-5336(2012) · Mapped (2) |
| Characterization of retinoic acid-inducible gene-I (RIG-I) expression corresponding to viral infection and UVB in human keratinocytes. Kimura K., Matsuzaki Y., Nishikawa Y., Kitamura H., Akasaka E., Rokunohe D., Nakano H., Imaizumi T., Satoh K., Sawamura D. J. Dermatol. Sci. 66:64-70(2012) · Mapped (1) |
| Interleukin-11 links oxidative stress and compensatory proliferation. Nishina T., Komazawa-Sakon S., Yanaka S., Piao X., Zheng D.M., Piao J.H., Kojima Y., Yamashina S., Sano E., Putoczki T. et al. Sci Signal 5:ra5-ra5(2012) · Mapped (6) |
| Importin beta1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells. Kojima Y., Nakayama M., Nishina T., Nakano H., Koyanagi M., Takeda K., Okumura K., Yagita H. J. Biol. Chem. 286:43383-43393(2011) · Mapped (8) |
| Pulmonary CD103(+) dendritic cells prime Th2 responses to inhaled allergens. Nakano H., Free M.E., Whitehead G.S., Maruoka S., Wilson R.H., Nakano K., Cook D.N. Mucosal Immunol 5:53-65(2012) · Mapped (7) |
| IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. Whitehead G.S., Wilson R.H., Nakano K., Burch L.H., Nakano H., Cook D.N. J. Allergy Clin. Immunol. 129:207-15.e1-5(2012) · Mapped (4) |
| Two cases of recessive dystrophic epidermolysis bullosa diagnosed as severe generalized. Ohashi M., Shu E., Nagai M., Murase K., Nakano H., Tamai K., Sawamura D., Hiroka T., Seishima M., Kitajima Y. et al. J. Dermatol. 38:893-899(2011) · Mapped (2) |
| RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis. Funasaka T., Nakano H., Wu Y., Hashizume C., Gu L., Nakamura T., Wang W., Zhou P., Moore M.A., Sato H. et al. Cell Cycle 10:1456-1467(2011) · Mapped (11) |
| SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Tokunaga F., Nakagawa T., Nakahara M., Saeki Y., Taniguchi M., Sakata S., Tanaka K., Nakano H., Iwai K. |
| Tumor necrosis factor receptor-associated factor (TRAF) 2 controls homeostasis of the colon to prevent spontaneous development of murine inflammatory bowel disease. Piao J.H., Hasegawa M., Heissig B., Hattori K., Takeda K., Iwakura Y., Okumura K., Inohara N., Nakano H. J. Biol. Chem. 286:17879-17888(2011) · Mapped (16) |
| Structural basis for docking of peroxisomal membrane protein carrier Pex19p onto its receptor Pex3p. Sato Y., Shibata H., Nakatsu T., Nakano H., Kashiwayama Y., Imanaka T., Kato H. |
| Relation between the expression levels of the POU transcription factors Skn-1a and Skn-1n and keratinocyte differentiation. Takemoto H., Tamai K., Akasaka E., Rokunohe D., Takiyoshi N., Umegaki N., Nakajima K., Aizu T., Kaneko T., Nakano H. et al. J. Dermatol. Sci. 60:203-205(2010) · Mapped (1) |
| The exquisite structure and reaction mechanism of bacterial Pz-peptidase A toward collagenous peptides: X-ray crystallographic structure analysis of PZ-peptidase a reveals differences from mammalian thimet oligopeptidase. Kawasaki A., Nakano H., Hosokawa A., Nakatsu T., Kato H., Watanabe K. J. Biol. Chem. 285:34972-34980(2010) · UniProtKB (1) |
| A method for reverse interactome analysis: High-resolution mapping of interdomain interaction network in Dam1 complex and its specific disorganization based on the interaction domain expression. Ikeuchi A., Nakano H., Kamiya T., Yamane T., Kawarasaki Y. Biotechnol. Prog. 26:945-953(2010) · Mapped (7) |
| GI24 enhances tumor invasiveness by regulating cell surface membrane-type 1 matrix metalloproteinase. Sakr M.A., Takino T., Domoto T., Nakano H., Wong R.W., Sasaki M., Nakanuma Y., Sato H. Cancer Sci. 101:2368-2374(2010) · Mapped (10) |
| TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation. Missiou A., Rudolf P., Stachon P., Wolf D., Varo N., Aichele P., Colberg C., Hoppe N., Ernst S., Munkel C. et al. Circ. Res. 107:757-766(2010) · Mapped (10) |
| Characterization of the role of the tumor marker Nup88 in mitosis. Hashizume C., Nakano H., Yoshida K., Wong R.W. Mol. Cancer 9:119-119(2010) · Mapped (3) |
| Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat. Izumi K., Nakamura S., Nakano H., Shimura K., Sakagami Y., Oishi S., Uchiyama S., Ohkubo T., Kobayashi Y., Fujii N. et al. Antiviral Res. 87:179-186(2010) · Mapped (1) |
| Serum levels of surfactant protein D predict the anti-tumor activity of gefitinib in patients with advanced non-small cell lung cancer. Yamaguchi H., Soda H., Nakamura Y., Takasu M., Tomonaga N., Nakano H., Doi S., Nakatomi K., Nagashima S., Takatani H. et al. Cancer Chemother. Pharmacol. 67:331-338(2011) · Mapped (2) |
| Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling. Ando K., Hasegawa K., Shindo K., Furusawa T., Fujino T., Kikugawa K., Nakano H., Takeuchi O., Akira S., Akiyama T. et al. FEBS J. 277:2051-2066(2010) · Mapped (15) |
| Brain-derived neurotrophic factor treatment increases the skeletal muscle glucose transporter 4 protein expression in mice. Suwa M., Yamamoto K.I., Nakano H., Sasaki H., Radak Z., Kumagai S. Physiol Res 59:619-623(2010) · Mapped (1) |